The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Inhibition of Angiogenesis by Interleukin 4
Open accessAbstract
Interleukin (IL)-4, a crucial modulator of the immune system and an active antitumor agent, is also a potent inhibitor of angiogenesis. When incorporated at concentrations of 10 ng/ml or more into pellets implanted into the rat cornea or when delivered systemically to the mouse by intraperitoneal injection, IL-4 blocked the induction of corneal neovascularization by basic fibroblast growth factor. IL-4 as well as IL-13 inhibited the migration of cultured bovine or human microvascular cells, showing unusual dose–response curves that were sharply stimulatory at a concentration of 0.01 ng/ml but inhibitory over a wide range of higher concentrations. Recombinant cytokine from mouse and from human worked equally well in vitro on bovine and human endothelial cells and in vivo in the rat, showing no species specificity. IL-4 was secreted at inhibitory levels by activated murine T helper (TH0) cells and by a line of carcinoma cells whose tumorigenicity is known to be inhibited by IL-4. Its ability to cause media conditioned by these cells to be antiangiogenic suggested that the antiangiogenic activity of IL-4 may play a role in normal physiology and contribute significantly to its demonstrated antitumor activity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Endostatin: an endogenous inhibitor of angiogenesis and tumor growth
O'Reilly, M. S., Boehm, T., Shing, Y., Fukai, N., Vasios, G., Lane, W. S., Flynn, E., Birkhead, J. R., Olsen, B. R., & Folkman, J. (1997) · Cell · doi:10.1016/s0092-8674(00)81848-6 · Cited by 4,486
O'Reilly, M. (1994) · Cell · doi:10.1016/0092-8674(94)90200-3 · Cited by 3,345
Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance
Boehm, T., Folkman, J., Browder, T., & O'Reilly, M. S. (1997) · Nature · doi:10.1038/37126 · Cited by 1,683 · cited 1×
“5 mg/kg/d which compares favorably with the doses needed to produce the same effect with other inhibitors of angiogenesis including the 5–10 mg/kg/d needed for 450-kD thrombospondin-1 (20), the 6–100 mg/kg/d required for 38–45-kD angiostatin (42, 43) and 20 mg/kg/d for 20-kD endostatin (44).”
BackgroundControl of Angiogenesis in Fibroblasts by p53 Regulation of Thrombospondin-1
Dameron, K. M., Volpert, O. V., Tainsky, M. A., & Bouck, N. (1994) · Science · doi:10.1126/science.7521539 · Cited by 1,438
Self-citationGeneration and Analysis of Interleukin-4 Deficient Mice
Kühn, R., Rajewsky, K., & Müller, W. (1991) · Science · doi:10.1126/science.1948049 · Cited by 1,248
Disruption of the murine IL-4 gene blocks Th2 cytokine responses
Kopf, M., Gros, G. L., Bachmann, M., Lamers, M. C., Bluethmann, H., & Köhler, G. (1993) · Nature · doi:10.1038/362245a0 · Cited by 1,203
Good, D. J., Polverini, P. J., Rastinejad, F., Le Beau, M. M., Lemons, R. S., Frazier, W. A., & Bouck, N. P. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.17.6624 · Cited by 1,054
Self-citationInterleukin-4: a prototypic immunoregulatory lymphokine
Paul, W. (1991) · Blood · doi:10.1182/blood.v77.9.1859.1859 · Cited by 880
Murine interleukin-4 displays potent anti-tumor activity in vivo
Tepper, R. I., Pattengale, P. K., & Leder, P. (1989) · Cell · doi:10.1016/0092-8674(89)90925-2 · Cited by 778
Self-citationProduction of a monoclonal antibody to and molecular characterization of B-cell stimulatory factor-1
Ohara, J., & Paul, W. E. (1985) · Nature · doi:10.1038/315333a0 · Cited by 726
Treatment of Established Renal Cancer by Tumor Cells Engineered to Secrete Interleukin-4
Golumbek, P. T., Lazenby, A. J., Levitsky, H. I., Jaffee, L. M., Karasuyama, H., Baker, M., & Pardoll, D. M. (1991) · Science · doi:10.1126/science.1948050 · Cited by 719
CD36 Mediates the In Vitro Inhibitory Effects of Thrombospondin-1 on Endothelial Cells
Dawson, D. W., Pearce, S. F. A., Zhong, R., Silverstein, R. L., Frazier, W. A., & Bouck, N. P. (1997) · The Journal of Cell Biology · doi:10.1083/jcb.138.3.707 · Cited by 676
Self-citationTolsma, S., Volpert, O., Good, D., Frazier, W., Polverini, P., & Bouck, N. (1993) · The Journal of cell biology · doi:10.1083/jcb.122.2.497 · Cited by 573
Self-citationAn Eosinophil-Dependent Mechanism for the Antitumor Effect of Interleukin-4
Tepper, R. I., Coffman, R. L., & Leder, P. (1992) · Science · doi:10.1126/science.1636093 · Cited by 541
Self-citation(1996) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60862-3 · Cited by 510
Haraldsen, G., Kvale, D., Lien, B., Farstad, I. N., & Brandtzaeg, P. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.7.2558 · Cited by 424
Leder, A., Pattengale, P. K., Kuo, A., Stewart, T. A., & Leder, P. (1986) · Cell · doi:10.1016/0092-8674(86)90280-1 · Cited by 423
A model of angiogenesis in the mouse cornea.
Kenyon, B. M., Voest, E. E., Chen, C. C., Flynn, E. A., Folkman, J., & D’Amato, R. J. (1996) · PubMed · Cited by 407
Sugamura, K., Asao, H., Kondo, M., Tanaka, N., Ishii, N., Ohbo, K., Nakamura, M., & Takeshita, T. (1996) · Annual Review of Immunology · doi:10.1146/annurev.immunol.14.1.179 · Cited by 407
Finkelman, F. D., Katona, I. M., Urban, J. F., Snapper, C. M., Ohara, J., & Paul, W. E. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.24.9675 · Cited by 349
cDNA Cloning and Characterization of the Human Interleukin 13 Receptor α Chain
Aman, M. J., Tayebi, N., Obiri, N. I., Puri, R. K., Modi, W. S., & Leonard, W. J. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.46.29265 · Cited by 281
Receptors for B-cell stimulatory factor-1 expressed on cells of haematopoietic lineage
Ohara, J., & Paul, W. E. (1987) · Nature · doi:10.1038/325537a0 · Cited by 279
Regulation of vascular cell adhesion molecule 1 on human dermal microvascular endothelial cells
Swerlick, R. A., Lee, K. H., Li, L. J., Sepp, N. T., Caughman, S. W., & Lawley, T. J. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.149.2.698 · Cited by 264
Gately, S. T., Twardowski, P., Stack, M. S., Patrick, M., Boggio, L. N., Cundiff, D. L., Schnaper, H. W., Madison, L. D., Volpert, O. V., Bouck, N., et al. (1996) · PubMed · Cited by 197
Self-citationPetzelbauer, P., Bender, J. R., Wilson, J., & Pober, J. S. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.151.9.5062 · Cited by 187
Volpert, O. V., Lawler, J., & Bouck, N. P. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6343 · Cited by 186
Self-citationvan Roon, J. A. G., van Roy, J. L. A. M., Gmelig‐Meyling, F. H. J., Lafeber, F. P. J. G., & Bijlsma, J. W. J. (1996) · Arthritis & Rheumatism · doi:10.1002/art.1780390516 · Cited by 176
Mosmann, T. R., Yokota, T., Kastelein, R., Zurawski, S. M., Arai, N., & Takebe, Y. (1987) · The Journal of Immunology · doi:10.4049/jimmunol.138.6.1813 · Cited by 169
Allen, J. B., Wong, H. L., Costa, G. L., Bienkowski, M. J., & Wahl, S. M. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.151.8.4344 · Cited by 168
Inhibition of colon and breast carcinoma cell growth by interleukin-4.
Toi, M., Bicknell, R., & Harris, A. L. (1992) · PubMed · Cited by 166
Schnyder, B., Lugli, S. M., Feng, N., Etter, H., Lutz, R. A., Ryffel, B., Sugamura, K., Wunderli‐Allenspach, H., & Moser, R. (1996) · Blood · doi:10.1182/blood.v87.10.4286.bloodjournal87104286 · Cited by 136
Palmer-Crocker, R., Hughes, C. C. W., & Pober, J. S. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118829 · Cited by 114
Interleukin-4 is a potent mitogen for capillary endothelium
Toi, M., Harris, A. L., & Bicknell, R. (1991) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(91)91561-p · Cited by 101
Suppression of Tumor Growth with Recombinant Murine Angiostatin
Wu, Z., O’Reilly, M. S., Folkman, J., & Shing, Y. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.7032 · Cited by 92
Two competing influences that may explain concomitant tumor resistance.
Prehn, R. T. (1993) · PubMed · Cited by 88
Kotowicz, K., Callard, R. E., Friedrich, K., Matthews, D. J., & Klein, N. J. (1996) · International Immunology · doi:10.1093/intimm/8.12.1915 · Cited by 82
Assay and purification of naturally occurring inhibitor of angiogenesis
Polverini, P. J., Bouck, N., & Rastinejad, F. (1991) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/0076-6879(91)98044-7 · Cited by 70
Self-citationInterleukin-4 and Cancer Therapy
Puri, R. K., & Siegel, J. P. (1993) · Cancer Investigation · doi:10.3109/07357909309018879 · Cited by 63
Topp, M. S., PAPADIMITRIOU, C. A., Eitelbach, F., Koenigsmann, M., Oelmann, E. M., Koehler, B., Oberberg, D., Reufi, B., Stein, H., & Thiel, E. (1995) · PubMed · Cited by 52
TNP-470/minocycline/cytotoxic therapy: A systems approach to cancer therapy
Teicher, B. A., Emi, Y., Kakeji, Y., & Northey, D. (1996) · European Journal of Cancer · doi:10.1016/s0959-8049(96)00380-2 · Cited by 52
Orchansky, P. L., Ayres, S. D., Hilton, D. J., & Schrader, J. W. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.36.22940 · Cited by 48
Lugli, S. M., Feng, N., Heim, M. H., Adam, M., Schnyder, B., Etter, H., Yamage, M., Eugster, H., Lutz, R. A., Zurawski, G., et al. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.9.5487 · Cited by 45
Hillman, G. G., Younes, E., Visscher, D. W., Ali, E., Lam, J. S., Montecillo, E. J., Pontes, J. E., Haas, G. P., & Puri, R. K. (1995) · Cellular Immunology · doi:10.1016/0008-8749(95)80036-i · Cited by 29
Cited by
Mechanisms of normal and tumor-derived angiogenesis
Papetti, M., & Herman, I. M. (2002) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00389.2001 · Cited by 809
Angiogenesis: regulators and clinical applications
Liekens, S., De Clercq, E., & Neyts, J. (2001) · Biochemical Pharmacology · doi:10.1016/s0006-2952(00)00529-3 · Cited by 748
Osteoarthritis, angiogenesis and inflammation
Bonnet, C. S. (2005) · Rheumatology · doi:10.1093/rheumatology/keh344 · Cited by 709
Endogenous Inhibitors of Angiogenesis
Nyberg, P., Xie, L., & Kalluri, R. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-2427 · Cited by 553
IL-4 in the brain: a cytokine to remember
Gadani, S. P., Cronk, J. C., Norris, G. T., & Kipnis, J. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1202246 · Cited by 549
Metadata
- Authors
- Volpert, O. V., Fong, T., Koch, A. E., Peterson, J. D., Waltenbaugh, C., Tepper, R. I., & Bouck, N. P.
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 1998-09-21
- Volume
- 188
- Issue
- 6
- Pages
- 1039-1046
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2032106677
- Cited by
- 255
- References
- 43
- FWCI
- 3.94
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.